Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies

Abstract Hematological malignancies are typically treated with chemotherapy and radiotherapy as the first-line conventional therapies. However, non-coding RNAs (ncRNAs) are a rapidly expanding field of study in cancer biology that influences the growth, differentiation, and proliferation of tumors b...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cancer Cell International
المؤلفون الرئيسيون: Samira Anvari, Mohsen Nikbakht, Mohammad Vaezi, Sedigheh Amini-Kafiabad, Mohammad Ahmadvand
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2024-12-01
الموضوعات:
miRNA
lncRNA
Leukemia
Immune checkpoints
Immunotherapy
الوصول للمادة أونلاين:https://doi.org/10.1186/s12935-024-03596-8

الانترنت

https://doi.org/10.1186/s12935-024-03596-8

مواد مشابهة